News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
61,886 Results
Type
Article (1785)
Company Profile (5)
Press Release (60096)
Section
Business (29447)
Career Advice (59)
Deals (4420)
Drug Delivery (3)
Drug Development (7056)
Employer Resources (11)
FDA (1270)
Job Trends (1814)
News (40476)
Policy (2259)
Tag
Academia (140)
Accelerated approval (1)
Allergies (9)
Alliances (2357)
ALS (13)
Alzheimer's disease (91)
Antibody-drug conjugate (ADC) (6)
Approvals (1303)
Artificial intelligence (18)
Autoimmune disease (1)
Automation (1)
Bankruptcy (5)
Best Places to Work (1711)
Biosimilars (7)
Biotechnology (7)
Bladder cancer (17)
Brain cancer (1)
Breast cancer (43)
Cancer (256)
Cardiovascular disease (27)
Career advice (52)
CAR-T (5)
Cell therapy (27)
Cervical cancer (2)
Clinical research (6277)
Collaboration (42)
Compensation (57)
COVID-19 (205)
CRISPR (3)
C-suite (20)
Cystic fibrosis (9)
Data (360)
Depression (3)
Diabetes (21)
Diagnostics (652)
Digital health (2)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (9)
Drug pricing (3)
Duchenne muscular dystrophy (22)
Earnings (25932)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6129)
Executive appointments (32)
FDA (1478)
Frontotemporal dementia (3)
Funding (46)
Gene editing (6)
Generative AI (1)
Gene therapy (26)
GLP-1 (91)
Government (289)
Guidances (97)
Healthcare (2023)
Huntington's disease (2)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (5)
Infectious disease (220)
Inflammatory bowel disease (16)
Influenza (7)
Intellectual property (3)
Interviews (3)
IPO (3294)
IRA (3)
Job creations (175)
Job search strategy (51)
Kidney cancer (1)
Labor market (3)
Layoffs (26)
Legal (400)
Liver cancer (6)
Lung cancer (50)
Lymphoma (20)
Management (2)
Manufacturing (17)
MASH (15)
Medical device (1601)
Medtech (1601)
Mergers & acquisitions (1196)
Metabolic disorders (79)
Multiple sclerosis (12)
NASH (2)
Neurodegenerative disease (7)
Neuropsychiatric disorders (4)
Neuroscience (156)
NextGen: Class of 2025 (540)
Non-profit (247)
Now hiring (4)
Obesity (44)
Opinion (11)
Ovarian cancer (3)
Pain (6)
Pancreatic cancer (14)
Parkinson's disease (17)
Partnered (3)
Patents (9)
Patient recruitment (8)
Peanut (6)
People (2049)
Phase I (1466)
Phase II (2539)
Phase III (2672)
Pipeline (528)
Policy (9)
Postmarket research (280)
Preclinical (440)
Press Release (3)
Prostate cancer (9)
Radiopharmaceuticals (15)
Rare diseases (34)
Real estate (279)
Recruiting (4)
Regulatory (1749)
Reports (8)
Research institute (133)
Resumes & cover letters (6)
RSV (4)
Schizophrenia (7)
Series A (8)
Series B (3)
Sickle cell disease (4)
Special edition (1)
Spinal muscular atrophy (11)
Startups (128)
Stomach cancer (2)
Supply chain (1)
Tariffs (6)
The Weekly (1)
Vaccines (44)
Venture capitalists (3)
Weight loss (28)
Women's health (1)
Date
Today (36)
Last 7 days (242)
Last 30 days (517)
Last 365 days (4341)
2025 (1713)
2024 (4563)
2023 (5059)
2022 (5824)
2021 (6103)
2020 (5494)
2019 (4608)
2018 (3355)
2017 (2977)
2016 (2240)
2015 (2934)
2014 (2018)
2013 (1226)
2012 (1485)
2011 (1752)
2010 (1659)
Location
Africa (46)
Alabama (8)
Alaska (1)
Arizona (14)
Arkansas (1)
Asia (3328)
Australia (442)
California (802)
Canada (274)
China (62)
Colorado (62)
Connecticut (38)
Delaware (53)
Europe (9493)
Florida (105)
Georgia (50)
Idaho (4)
Illinois (49)
India (1)
Indiana (50)
Japan (19)
Kansas (28)
Kentucky (2)
Louisiana (4)
Maine (11)
Maryland (99)
Massachusetts (564)
Michigan (76)
Minnesota (44)
Missouri (10)
Montana (2)
Nevada (17)
New Hampshire (9)
New Jersey (264)
New York (200)
North Carolina (103)
Northern California (384)
Ohio (43)
Oregon (1)
Pennsylvania (207)
South America (64)
Southern California (329)
Tennessee (7)
Texas (105)
United States (3093)
Utah (32)
Virginia (7)
Washington D.C. (4)
Washington State (99)
Wisconsin (3)
61,886 Results for "72".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ESSENCE phase 3 trial of semaglutide showed significant improvements at 72 weeks in adults with MASH, published in NEJM
April 30, 2025
·
10 min read
Press Releases
Turn Therapeutics Announces Vaccine Breakthrough: Validates 100% VSV Recovery from Petrolatum Carrier at 24 and 72 Hours
May 2, 2025
·
2 min read
Press Releases
Groundbreaking Alzheimer’s and cancer studies receive $7.2M boost
February 5, 2025
·
2 min read
Press Releases
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2025 REVENUE +11.9%, EBITDA(1) +10.7%, ADJUSTED NET INCOME(2) +7.2%
May 8, 2025
·
19 min read
Press Releases
SineuGene Therapeutics Announces FDA IND Clearance for SNUG01, a First-in-Class TRIM72-Targeted Gene Therapy for ALS
March 24, 2025
·
3 min read
Press Releases
Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® Pipeline and Platform
March 17, 2025
·
7 min read
Press Releases
Biopharmaceutical CMO and CRO Market Size to Worth USD 72.39 Bn by 2034
February 6, 2025
·
1 min read
Press Releases
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager
April 28, 2025
·
8 min read
Press Releases
Whole Exome Sequencing Market to Reach USD 4.72 Billion by 2031
December 16, 2024
·
1 min read
Press Releases
Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025
March 25, 2025
·
2 min read
1 of 6,189
Next
